All subjects (n = 70) | |
---|---|
Age, years | 32.71 ± 11.65 (18–71) |
Sex | 41 (59) male |
Genotype n, (%) | |
F508del homozygous | 28 (40) |
F508del heterozygous | 31 (44) |
Other | 11 (16) |
BMI, kg/m2 | 20.32 ± 3.41 (15–33) |
ppFEV1 | 43.27 ± 19.93 (16–99) |
Pancreatic insufficiency n, % | 45 (64) |
CF-related diabetes n, % | 22 (31) |
P. aeruginosa positive n, % | 52 (74) |
Hospital n, % | |
Inpatient | 67 (96) |
Outpatient | 3 (4) |
Reasons for medical treatment n, % | |
PEX | 33 (47) |
Starting CFTR-Modulator Therapy | 14 (20) |
IVAT | 8 (11) |
Others | 16 (22) |
Marital status n,% | |
Single | 36 (51) |
In partnership / married | 34 (49) |